Detailed information for compound 1484350

Basic information

Technical information
  • TDR Targets ID: 1484350
  • Name: T5294140
  • MW: 436.497 | Formula: C21H25FN2O5S
  • H donors: 1 H acceptors: 3 LogP: 2.76 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1S(=O)(=O)N1CCCCC1)NC(=O)CCOc1ccccc1F
  • InChi: 1S/C21H25FN2O5S/c1-28-19-10-9-16(15-20(19)30(26,27)24-12-5-2-6-13-24)23-21(25)11-14-29-18-8-4-3-7-17(18)22/h3-4,7-10,15H,2,5-6,11-14H2,1H3,(H,23,25)
  • InChiKey: VXSNLNIKTKTRLK-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0421 0.2401 0.2525
Onchocerca volvulus 0.0996 0.9508 0.9387
Onchocerca volvulus 0.0996 0.9508 0.9387
Onchocerca volvulus 0.0996 0.9508 0.9387
Schistosoma mansoni hypothetical protein 0.0427 0.2475 0.2603
Echinococcus multilocularis tissue type plasminogen activator 0.0427 0.2475 0.5
Loa Loa (eye worm) hypothetical protein 0.0427 0.2475 0.0617
Plasmodium vivax cysteine repeat modular protein 1, putative 0.0427 0.2475 0.5
Onchocerca volvulus 0.0996 0.9508 0.9387
Brugia malayi SEA domain containing protein 0.0996 0.9508 0.9387
Brugia malayi Protein kinase domain containing protein 0.0427 0.2475 0.0617
Loa Loa (eye worm) TK/ROR protein kinase 0.0427 0.2475 0.0617
Brugia malayi Kringle domain containing protein 0.0427 0.2475 0.0617
Toxoplasma gondii kringle domain-containing protein 0.0427 0.2475 1
Onchocerca volvulus 0.1036 1 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0387 0.198 0.2083
Plasmodium falciparum cysteine repeat modular protein 1 0.0427 0.2475 0.5
Loa Loa (eye worm) hypothetical protein 0.0996 0.9508 0.9387
Loa Loa (eye worm) DOMON domain-containing protein 0.0996 0.9508 0.9387
Trypanosoma cruzi hypothetical protein, conserved 0.0427 0.2475 0.5
Loa Loa (eye worm) hypothetical protein 0.1036 1 1
Schistosoma mansoni hypothetical protein 0.0996 0.9508 1
Echinococcus granulosus tissue type plasminogen activator 0.0427 0.2475 0.5
Leishmania major hypothetical protein, conserved 0.0427 0.2475 0.5
Onchocerca volvulus 0.0427 0.2475 0.0617

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 10 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] ChEMBL. No reference
Potency (functional) 20.5962 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (functional) 23.0999 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] ChEMBL. No reference
Potency (functional) 28.1838 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.